Related Experiment Video
Updated: Apr 27, 2026

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature
Insights
Host-microbe interactions in the ileum are key to Crohn disease (CD) development. Specific gene expression and microbial profiles in the ileum predict disease and potential treatment responses in pediatric patients.
Area of Science:
- Gastroenterology
- Microbiology
- Genomics
Background:
- Gut microbial community interactions are implicated in Crohn disease (CD) pathogenesis.
- Direct evidence linking host-microbe interactions to early CD onset is limited.
Purpose of the Study:
- To characterize ileal gene expression and microbial communities in treatment-naive pediatric patients with CD, ulcerative colitis (UC), and controls.
- To identify host-microbe signatures specific to CD at the disease's onset.
Main Methods:
- Global ileal gene expression profiling.
- Ileal microbial community analysis (16S rRNA sequencing).
- Analysis of 359 treatment-naive pediatric patients (CD, UC, controls).
Main Results:
- Identified core ileal gene expression and microbial profiles specific to CD, independent of clinical inflammation.
- Observed increased dual oxidase (DUOX2) expression and Proteobacteria expansion in both UC and CD.
- Found downregulated apolipoprotein A1 (APOA1) gene expression linked to CD-specific Firmicutes alterations.
- CD-specific signatures correlated with oxidative stress, Th1 polarization, and mucosal injury severity.
- A model including APOA1 and microbial abundance predicted remission more accurately than clinical factors alone.
Conclusions:
- The ileum is the primary site for the induction of all forms of CD.
- CD-specific host-microbe profiles offer prognostic and therapeutic potential.
- Host-microbe interactions at disease onset are crucial for understanding CD pathogenesis.
Abstract:
Interactions between the host and gut microbial community likely contribute to Crohn disease (CD) pathogenesis; however, direct evidence for these interactions at the onset of disease is lacking. Here, we characterized the global pattern of ileal gene expression and the ileal microbial community in 359 treatment-naive pediatric patients with CD, patients with ulcerative colitis (UC), and control individuals. We identified core gene expression profiles and microbial communities in the affected CD ilea that are preserved in the unaffected ilea of patients with colon-only CD but not present in those with UC or control individuals; therefore, this signature is specific to CD and independent of clinical inflammation. An abnormal increase of antimicrobial dual oxidase (DUOX2) expression was detected in association with an expansion of Proteobacteria in both UC and CD, while expression of lipoprotein APOA1 gene was downregulated and associated with CD-specific alterations in Firmicutes. The increased DUOX2 and decreased APOA1 gene expression signature favored oxidative stress and Th1 polarization and was maximally altered in patients with more severe mucosal injury. A regression model that included APOA1 gene expression and microbial abundance more accurately predicted month 6 steroid-free remission than a model using clinical factors alone. These CD-specific host and microbe profiles identify the ileum as the primary inductive site for all forms of CD and may direct prognostic and therapeutic approaches.
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

